| Funding Opportunity ID: |
333645 |
| Opportunity Number: |
CDC-RFA-GH21-2173 |
| Opportunity Title: |
Capacity Building and Strengthening of Hospital Infection Control to detect, prevent and respond to antimicrobial resistance in India |
| Opportunity Category: |
Discretionary |
| Opportunity Category Explanation: |
|
| Funding Instrument Type: |
Cooperative Agreement |
| Category of Funding Activity: |
Health |
| Category Explanation: |
|
| CFDA Number(s): |
93.318 |
| Eligible Applicants: |
Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: |
The only eligible applicant to apply for this NOFO is All India Institute of Medical Sciences. The applicant must comply with Government of India Health Ministry’s Screening Committee (HMSC) clearance requirements if required and adhere to Government of India rules and regulations for foreign funding. |
| Agency Code: |
HHS-CDC-CGH |
| Agency Name: |
Department of Health and Human Services
Centers for Disease Control – CGH |
| Posted Date: |
May 18, 2021 |
| Close Date: |
Jul 20, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Last Updated Date: |
May 18, 2021 |
| Award Ceiling: |
$0 |
| Award Floor: |
$0 |
| Estimated Total Program Funding: |
$205,000,000 |
| Expected Number of Awards: |
1 |
| Description: |
Antimicrobial resistance (AMR) is a global patient safety and public health concern. Hospital acquired infections (HAI) lead to adverse outcomes and increased cost of treatment. Effective infection prevention and control (IPC) interventions can reduce HAIs. The Government of India has prioritized combating AMR. The All India Institute of Medical Science (AIIMS) at the direction of the Indian Council of Medical Research (ICMR) is directing the only standardized HAI surveillance network in India with 32 nodal centers in 22 states. Through this NOFO, AIIMS will work with CDC and ICMR to implement a step-wise, scalable approach to generate and report accurate HAI and AMR data. In the first year, sites will perform HAI surveillance, improve antimicrobial use and use data to target IPC activities. Short-term outcomes include develop a trained workforce; ensure standardization of surveillance; and strengthen IPC programs. The long-term objective is a sustainable AMR and HAI surveillance network that produces quality data to inform the development and implementation of evidence-based national policies on IPC, antimicrobial stewardship and HAI prevention. The Government of India has prioritized combating AMR. The All India Institute of Medical Science (AIIMS) at the direction of the Indian Council of Medical Research (ICMR) is directing the only standardized HAI surveillance network in India with 32 nodal centers in 22 states. Through this NOFO, AIIMS will work with CDC and ICMR to implement a step-wise, scalable approach to generate and report accurate HAI and AMR data. In the first year, sites will perform HAI surveillance, improve antimicrobial use and use data to target IPC activities. Short-term outcomes include develop a trained workforce; ensure standardization of surveillance; and strengthen IPC programs. The long-term objective is a sustainable AMR and HAI surveillance network that produces quality data to inform the development and implementation of evidence-based national policies on IPC, antimicrobial stewardship and HAI prevention. |
| Version: |
2 |
| Modification Comments: |
Due date amended to July 20, 2021. |
